Linscomb Wealth’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.74M | Sell |
66,281
-18,894
| -22% | -$1.81M | 0.26% | 82 |
|
|
2025
Q4 | $8.18M | Buy |
85,175
+1,760
| +2% | +$171K | 0.34% | 66 |
|
|
2025
Q3 | $7.94M | Buy |
83,415
+2,110
| +3% | +$194K | 0.34% | 66 |
|
|
2025
Q2 | $7.09M | Buy |
81,305
+1,825
| +2% | +$155K | 0.33% | 70 |
|
|
2025
Q1 | $7.14M | Buy |
79,480
+12,385
| +18% | +$1.11M | 0.36% | 67 |
|
|
2024
Q4 | $5.36M | Buy |
67,095
+1,266
| +2% | +$110K | 0.27% | 88 |
|
|
2024
Q3 | $5.93M | Buy |
65,829
+99
| +0.2% | +$8.33K | 0.29% | 80 |
|
|
2024
Q2 | $5.17M | Buy |
65,730
+110
| +0.2% | +$9.02K | 0.27% | 85 |
|
|
2024
Q1 | $5.72M | Buy |
65,620
+1,242
| +2% | +$106K | 0.29% | 80 |
|
|
2023
Q4 | $5.3M | Sell |
64,378
-1,597
| -2% | -$122K | 0.29% | 80 |
|
|
2023
Q3 | $5.17M | Sell |
65,975
-3,939
| -6% | -$330K | 0.3% | 76 |
|
|
2023
Q2 | $6.16M | Sell |
69,914
-2,487
| -3% | -$214K | 0.33% | 76 |
|
|
2023
Q1 | $5.84M | Buy |
72,401
+2,361
| +3% | +$192K | 0.31% | 75 |
|
|
2022
Q4 | $5.44M | Sell |
70,040
-319
| -0.5% | -$25.9K | 0.28% | 80 |
|
|
2022
Q3 | $5.68M | Buy |
70,359
+1,024
| +1% | +$92K | 0.34% | 74 |
|
|
2022
Q2 | $6.22M | Buy |
69,335
+3,120
| +5% | +$316K | 0.36% | 75 |
|
|
2022
Q1 | $7.35M | Buy |
66,215
+5,737
| +9% | +$606K | 0.35% | 73 |
|
|
2021
Q4 | $6.26M | Buy |
60,478
+1,964
| +3% | +$227K | 0.3% | 76 |
|
|
2021
Q3 | $7.33M | Buy |
58,514
+1,014
| +2% | +$131K | 0.38% | 72 |
|
|
2021
Q2 | $7.14M | Buy |
57,500
+2,437
| +4% | +$306K | 0.37% | 73 |
|
|
2021
Q1 | $6.5M | Buy |
55,063
+1,667
| +3% | +$195K | 0.35% | 74 |
|
|
2020
Q4 | $6.25M | Buy |
53,396
+1,474
| +3% | +$162K | 0.37% | 69 |
|
|
2020
Q3 | $5.4M | Buy |
51,922
+1,428
| +3% | +$143K | 0.37% | 67 |
|
|
2020
Q2 | $4.63M | Buy |
50,494
+10,055
| +25% | +$964K | 0.34% | 71 |
|
|
2020
Q1 | $3.65M | Buy |
40,439
+3,934
| +11% | +$419K | 0.32% | 65 |
|
|
2019
Q4 | $4.14M | Buy |
36,505
+859
| +2% | +$94.3K | 0.27% | 72 |
|
|
2019
Q3 | $3.87M | Buy |
35,646
+2,628
| +8% | +$274K | 0.31% | 66 |
|
|
2019
Q2 | $3.22M | Buy |
33,018
+933
| +3% | +$85.2K | 0.26% | 68 |
|
|
2019
Q1 | $2.92M | Buy |
32,085
+591
| +2% | +$52.9K | 0.25% | 74 |
|
|
2018
Q4 | $2.87M | Buy |
31,494
+1,503
| +5% | +$140K | 0.27% | 68 |
|
|
2018
Q3 | $2.95M | Buy |
29,991
+1,163
| +4% | +$108K | 0.24% | 72 |
|
|
2018
Q2 | $2.47M | Buy |
28,828
+3,049
| +12% | +$255K | 0.21% | 78 |
|
|
2018
Q1 | $2.07M | Buy |
25,779
+1,682
| +7% | +$139K | 0.18% | 82 |
|
|
2017
Q4 | $1.95M | Buy |
24,097
+17,448
| +262% | +$1.4M | 0.16% | 86 |
|
|
2017
Q3 | $517K | Sell |
6,649
-119
| -2% | -$9.88K | 0.04% | 166 |
|
|
2017
Q2 | $601K | Sell |
6,768
-216
| -3% | -$18.2K | 0.05% | 148 |
|
|
2017
Q1 | $563K | Sell |
6,984
-590
| -8% | -$46.1K | 0.05% | 153 |
|
|
2016
Q4 | $539K | Sell |
7,574
-1,572
| -17% | -$124K | 0.05% | 166 |
|
|
2016
Q3 | $790K | Buy |
9,146
+371
| +4% | +$32.3K | 0.08% | 119 |
|
|
2016
Q2 | $761K | Buy |
8,775
+471
| +6% | +$38.1K | 0.08% | 123 |
|
|
2016
Q1 | $623K | Sell |
8,304
-272
| -3% | -$20.5K | 0.07% | 139 |
|
|
2015
Q4 | $660K | Sell |
8,576
-637
| -7% | -$48K | 0.07% | 128 |
|
|
2015
Q3 | $617K | Sell |
9,213
-1,000
| -10% | -$73.7K | 0.07% | 133 |
|
|
2015
Q2 | $757K | Buy |
10,213
+540
| +6% | +$41.3K | 0.08% | 130 |
|
|
2015
Q1 | $754K | Buy |
9,673
+4,763
| +97% | +$361K | 0.08% | 128 |
|
|
2014
Q4 | $355K | Hold |
4,910
| – | – | 0.04% | 197 |
|
|
2014
Q3 | $304K | Buy |
4,910
+88
| +2% | +$5.59K | 0.03% | 220 |
|
|
2014
Q2 | $307K | Sell |
4,822
-242
| -5% | -$14.7K | 0.03% | 221 |
|
|
2014
Q1 | $312K | Buy |
+5,064
| New | +$295K | 0.03% | 208 |
|
|
2013
Q4 | – | Sell |
-4,394
| Closed | -$234K | – | 243 |
|
|
2013
Q3 | $234K | Hold |
4,394
| – | – | 0.03% | 209 |
|
|
2013
Q2 | $226K | Buy |
+4,394
| New | +$217K | 0.03% | 212 |
|
Other funds holding MDT
VCM
VPM
Linscomb Wealth's MDT Position: Q1 2026 in Review
Linscomb Wealth reduced its Medtronic (MDT) stake by 22% in Q1 2026, selling an estimated $1.81M and leaving 66,281 shares worth $5.74M. The position accounts for 0.26% of the portfolio, ranked #82.
Linscomb Wealth first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.18M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Linscomb Wealth held 66,281 shares of Medtronic worth $5.74M as of Q1 2026.
- Linscomb Wealth sold 18,894 Medtronic shares in Q1 2026, an estimated $1.81M.
- Medtronic made up 0.26% of Linscomb Wealth's portfolio in Q1 2026, its #82 holding.
- Linscomb Wealth first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
- Linscomb Wealth's Medtronic position peaked at $8.18M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Linscomb Wealth's 13F filing for Q1 2026, filed 11 May 2026.